ASHP Advantage: Therapeutic Thursdays: C.diff Therapeutics

The goal of the human microbiome project is to better understand the microbial components of our bodies and how this interface between micro-organisms and humans contribute to normal physiology and disease predisposition.  In this podcast, we will explore a classic microbiome disruption disease, namely C difficile infection.  Looking at C diff infection through the lens of the microbiome, we will explore the pathophysiology, treatment, and future of this important and devastating infectious disease.

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.